SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001358403-19-000094
Filing Date
2019-06-14
Accepted
2019-06-14 16:04:50
Documents
2
Period of Report
2019-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_156054267546231.html 4  
1 FORM 4 wf-form4_156054267546231.xml 4 3921
2 POWER OF ATTORNEY poa-jamesbrown.htm EX-24 3321
  Complete submission text file 0001358403-19-000094.txt   8762
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LANDMARK INFRASTRUCTURE PARTNERS LP 2141 ROSECRANS AVENUE, SUITE 2100 EL SEGUNDO CA 90245
Business Address
BROWN JAMES F (Reporting) CIK: 0001624379 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36783 | Film No.: 19898880